| HACKENSACK, N.J., July 18, 2012 /PRNewswire/ -- Champions Oncology, Inc. (OTC: CSBR), formerly Champions Biotechnology, Inc., engages in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today its financial results for the year ended April 30, 2012. Joel Ackerman, the CEO of Champions Oncology, stated, "Fiscal 2012 was a year of great progress for the company. We demonstrated our ability to drive significant ...continued CSBR Healthcare Drugs |
Wednesday, July 18, 2012
Champions Oncology Reports Financial Results for the Year Ended April 30, 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment